Testing effectiveness (Phase 2)Study completedNCT00204633
What this trial is testing
Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP)
Who this might be right for
Dysgerminoma
University Hospital Tuebingen 108